These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22682546)

  • 1. Immunohistochemical and morphometric evaluation of neuronal dysfunction in pelviureteral junction obstruction.
    Gündüz M; Yurtçu M; Toy H; Abasiyanik A; Demirci S
    J Pediatr Urol; 2013 Jun; 9(3):359-63. PubMed ID: 22682546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cell line-derived neurotrophic factor and synaptophysin expression in pelviureteral junction obstruction.
    Demirbilek S; Edali MN; Gürünlüoğlu K; Türkmen E; Taş E; Karaman A; Akin M; Aksoy RT; Celbis O; Uzün I
    Urology; 2006 Feb; 67(2):400-5. PubMed ID: 16461096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal defects an etiological factor in congenital pelviureteric junction obstruction?
    How GY; Chang KTE; Jacobsen AS; Yap TL; Ong CCP; Low Y; Allen JC; Kuick CH; Lim MZL; Laksmi NK
    J Pediatr Urol; 2018 Feb; 14(1):51.e1-51.e7. PubMed ID: 28927720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal innervation and altered nerve growth factor messenger ribonucleic acid expression in ureteropelvic junction obstruction.
    Wang Y; Puri P; Hassan J; Miyakita H; Reen DJ
    J Urol; 1995 Aug; 154(2 Pt 2):679-83. PubMed ID: 7609154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of histopathologic changes in pelviureteral junction obstruction.
    Yurtçu M; Gürbüzer N; Findik S; Avunduk MC; Günel E
    Ren Fail; 2010 Jan; 32(2):162-6. PubMed ID: 20199176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction.
    Kajbafzadeh AM; Payabvash S; Salmasi AH; Monajemzadeh M; Tavangar SM
    J Urol; 2006 Aug; 176(2):718-23; discussion 723. PubMed ID: 16813927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal unilateral pelviureteral junction obstruction: impact of pyeloplasty and conservative management on renal function.
    Shokeir AA; El-Sherbiny MT; Gad HM; Dawaba M; Hafez AT; Taha MA; Saida M; Ghaly AM
    Urology; 2005 May; 65(5):980-5; discussion 985. PubMed ID: 15882736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of Cajal like cells and innervation in intrinsic ureteropelvic junction obstruction.
    Kuvel M; Canguven O; Murtazaoglu M; Albayrak S
    Arch Ital Urol Androl; 2011 Sep; 83(3):128-32. PubMed ID: 22184836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of interstitial cells of Cajal in congenital ureteropelvic junction obstruction.
    Solari V; Piotrowska AP; Puri P
    J Urol; 2003 Dec; 170(6 Pt 1):2420-2. PubMed ID: 14634443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexisting pelviureteral and vesicoureteral junction obstruction in children.
    Pesce C; Musi L; Campobasso P; Costa L; Fabbro M
    Eur J Pediatr Surg; 2003 Dec; 13(6):367-71. PubMed ID: 14743322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelviureteral junction obstruction: correlation of renal cell apoptosis and differential renal function.
    Lama G; Ferraraccio F; Iaccarino F; Luongo I; Marte A; Rambaldi PF; Esposito-Salsano M
    J Urol; 2003 Jun; 169(6):2335-8. PubMed ID: 12771794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal cystic mass with pelviureteral junction obstruction.
    Moon D; Frydenberg A; Dewan PA
    Urology; 2000 May; 55(5):775. PubMed ID: 10792109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of interstitial cells of Cajal in primary obstructive megaureter.
    Kart Y; Karakuş OZ; Ateş O; Hakgüder G; Olguner M; Akgür FM
    J Pediatr Urol; 2013 Dec; 9(6 Pt B):1028-31. PubMed ID: 23498667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural changes of smooth muscle in congenital ureteropelvic junction obstruction.
    Hosgor M; Karaca I; Ulukus C; Ozer E; Ozkara E; Sam B; Ucan B; Kurtulus S; Karkiner A; Temir G
    J Pediatr Surg; 2005 Oct; 40(10):1632-6. PubMed ID: 16226997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early alteration of urinary exosomal aquaporin 1 and transforming growth factor β1 after release of unilateral pelviureteral junction obstruction.
    Li ZZ; Zhao ZZ; Wen JG; Xing L; Zhang H; Zhang Y
    J Pediatr Surg; 2012 Aug; 47(8):1581-6. PubMed ID: 22901921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered anoctamin-1 and tyrosine phosphorylation in congenital ureteropelvic junction obstruction.
    Hunziker M; O'Donnell AM; Gosemann J; Alvarez LA; Puri P
    J Pediatr Surg; 2020 Aug; 55(8):1621-1625. PubMed ID: 32087933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered cytoskeletal structure of smooth muscle cells in ureteropelvic junction obstruction.
    Cutroneo G; Arena S; Anastasi G; Cervellione RM; Grimaldi S; Di Mauro D; Speciale F; Arena F; Di Benedetto V; Favaloro A; Magno C
    J Urol; 2011 Jun; 185(6):2314-9. PubMed ID: 21511284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between impaired autophagy and the development of congenital ureteropelvic junction obstruction.
    Tourchi A; Kajbafzadeh AM; Ebadi M; Tavangar SM; Jarooghi N
    Urology; 2014 Dec; 84(6):1467-74. PubMed ID: 25440825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thickness of the renal pelvis smooth muscle indicates the postoperative course of ureteropelvic junction obstruction treatment].
    Kaselas C; Aggelidou S; Papouis G; Kazakis C; Philippopoulos A
    Actas Urol Esp; 2011; 35(10):605-9. PubMed ID: 21831482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive surgery for pelviureteral junction obstruction in adults: a critical review of the options.
    Manikandan R; Saad A; Bhatt RI; Neilson D
    Urology; 2005 Mar; 65(3):422-32. PubMed ID: 15780349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.